Menengai Medical Ltd 13192153 false 2023-03-01 2024-02-29 2024-02-29 The principal activity of the company is Specialist medical practice activities Digita Accounts Production Advanced 6.30.9574.0 true 13192153 2023-03-01 2024-02-29 13192153 2024-02-29 13192153 bus:Director1 1 2024-02-29 13192153 core:CurrentFinancialInstruments core:WithinOneYear 2024-02-29 13192153 bus:Micro-entities 2023-03-01 2024-02-29 13192153 bus:AuditExemptWithAccountantsReport 2023-03-01 2024-02-29 13192153 bus:FilletedAccounts 2023-03-01 2024-02-29 13192153 bus:SmallCompaniesRegimeForAccounts 2023-03-01 2024-02-29 13192153 bus:RegisteredOffice 2023-03-01 2024-02-29 13192153 bus:Director1 2023-03-01 2024-02-29 13192153 bus:Director1 1 2023-03-01 2024-02-29 13192153 bus:PrivateLimitedCompanyLtd 2023-03-01 2024-02-29 13192153 countries:EnglandWales 2023-03-01 2024-02-29 13192153 bus:Director1 1 2023-02-28 13192153 2022-03-01 2023-02-28 13192153 2023-02-28 13192153 bus:Director1 1 2023-02-28 13192153 core:CurrentFinancialInstruments core:WithinOneYear 2023-02-28 13192153 bus:Director1 1 2022-03-01 2023-02-28 13192153 bus:Director1 1 2022-02-28 iso4217:GBP xbrli:pure

Registration number: 13192153

Menengai Medical Ltd

Annual Report and Unaudited Financial Statements

for the Year Ended 29 February 2024

 

Menengai Medical Ltd

Contents

Balance Sheet

1

Notes to the Unaudited Financial Statements

2

 

Menengai Medical Ltd

(Registration number: 13192153)
Balance Sheet as at 29 February 2024

2024
£

2023
£

Fixed assets

1,958

1,142

Current assets

33,101

23,787

Prepayments and accrued income

-

8,602

Creditors: Amounts falling due within one year

(16,909)

(25,702)

Net current assets

16,192

6,687

Total assets less current liabilities

18,150

7,829

Accruals and deferred income

(4,470)

(4,152)

 

13,680

3,677

Capital and reserves

13,680

3,677

For the financial year ending 29 February 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 24 March 2025
 

A Harris
Director

   
     
 

Menengai Medical Ltd

Notes to the Unaudited Financial Statements for the Year Ended 29 February 2024

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
5 Chapel Court
Chudleigh
Devon
TQ13 0FH
UK

These financial statements were authorised for issue by the director on 24 March 2025.

Basis of preparation

The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.

The financial statements are prepared in sterling, which is the functional currency of the company, and rounded to the nearest £.

2

Staff numbers

The average number of persons employed by the company (including the director) during the year was 1 (2023 - 1).

3

Related party transactions

During the year a loan was made to the director. Interest was charged at 2% where applicable and the loan was repayable on demand.

Transactions with the director

2024

At 1 March 2023
£

Advances to director
£

Repayments by director
£

At 29 February 2024
£

A Harris

(3,565)

43,432

(38,176)

1,691

2023

At 1 March 2022
£

Advances to director
£

Repayments by director
£

At 28 February 2023
£

A Harris

(1,064)

35,549

(38,050)

(3,565)